Reasons for participation and nonparticipation in colorectal cancer screening: A randomized trial of colonoscopy and CT colonography

American Journal of Gastroenterology

Volumn 107, Issue 12, 2012, Pages 1777-1783

  De Wijkerslooth, Thomas R ^a   De Haan, Margriet C ^a   Stoop, Esther M ^b   Bossuyt, Patrick M ^a   Thomeer, Maarten ^b   Van Leerdam, Monique E ^b   Essink Bot, Marie Louise ^a   Fockens, Paul ^a   Kuipers, Ernst J ^b   Stoker, Jaap ^a   Dekker, Evelien ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTROLLED STUDY; COPING BEHAVIOR; EARLY DIAGNOSIS; FAMILY CONFLICT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; MULTICENTER STUDY; PATIENT PARTICIPATION; PATIENT SAFETY; PRECANCER; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCIENCE; SYMPTOM; TIME; TREATMENT REFUSAL;

AGE DISTRIBUTION; AGE FACTORS; AGED; COLONIC NEOPLASMS; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SAMPLING STUDIES; SEX DISTRIBUTION; SEX FACTORS;

EID: 84870848349     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.140     Document Type: Article

References (23)

1. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
2. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:1541-9.
3. Rex DK, Johnson DA, Anderson JC et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009;104:739-50.
4. Scott RG, Edwards JT, Fritschi L et al. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am J Gastroenterol 2004;99:1145-51.
5. Brenner H, Hoffmeister M, Brenner G et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1, 875, 708 screening colonoscopies. Eur J Cancer 2009;45:2027-33.
6. Irwig L, McCaffery K, Salkeld G et al. Informed choice for screening: implications for evaluation. BMJ 2006;332:1148-50.
7. Javanparast S, Ward P, Young G et al. How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Prev Med 2010;50:165-72.
8. de Wijkerslooth TR, de Haan MC, Stoop EM et al. Study protocol: population screening for colorectal cancer by colonoscopy or CT colonography: a randomized controlled trial. BMC Gastroenterol [online] 2010;10:47.
9. Stoop EM, de Haan MC, de Wijkerslooth TR et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012;13:55-64.
10. Centraal Bureau voor de Statistiek (Statistics Netherlands).
11. Denters MJ, Deutekom M, Fockens P et al. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands. BMC Gastroenterol [online] 2009;9:28.
12. Hol L, Van Leerdam ME, van Ballegooijen M et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010;59:62-8.
13. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
14. van den Bergh KA, Essink-Bot ML, van Klaveren RJ et al. Informed participation in a randomised controlled trial of computed tomography screening for lung cancer. Eur Respir J 2009;34:711-20.
15. Nijs HG, Essink-Bot ML, DeKoning HJ et al. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med 2000;22:312-6.
16. Winawer SJ, Zauber AG, Ho MN et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993;329:1977-81.
17. Castillo AG, Jandorf L, Thelemaque LD et al. Reported benefits of participation in a research study. J Community Health 2012;37:59-64.
18. Renaut AJ, Raniga S, Frizelle FA et al. A randomized controlled trial comparing the efficacy and acceptability of phospo-soda buffered saline (Fleet) with sodium picosulphate/magnesium citrate (Picoprep) in the preparation of patients for colonoscopy. Colorectal Dis 2008;10:503-5.
19. Burling D. CT colonography standards. Clin Radiol 2010;65:474-80.
20. de Wijkerslooth TR, de Haan MC, Stoop EM et al. Burden of colonoscopy compared to non-cathartic CT colonography in a colorectal cancer screening program: randomized controlled trial. Gut 2012;61:1552-9.
21. Hewitson P, Austoker J. Part 2: Patient information, informed decisionmaking and the psycho-social impact of prostate-specific antigen testing. BJU Int 2005;95(Suppl 3):16-32.
22. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
23. von Karsa L, Anttila A, Ronco G et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening http://ec. europa. eu/health/ph-determinants/genetics/documents/ cancer-screening. pdf.